Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 790460, 27 pages
http://dx.doi.org/10.1155/2011/790460
Review Article

Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes

1Department of Neuroscience, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
2Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy

Received 15 October 2010; Revised 12 January 2011; Accepted 19 January 2011

Academic Editor: Carl Feng

Copyright © 2011 Angelo Aquino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Lin and J. L. Flynn, “Understanding latent tuberculosis: a moving target,” Journal of Immunology, vol. 185, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at PubMed
  2. J. L. Flynn, J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, “An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2249–2254, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Porcelli, M. B. Brenner, J. L. Greenstein, S. P. Balk, C. Terhorst, and P. A. Bleicher, “Recognition of cluster of differentiation 1 antigens by human CD4 CD8 cytolytic T lymphocytes,” Nature, vol. 341, no. 6241, pp. 447–450, 1989. View at Google Scholar · View at Scopus
  4. S. Porcelli, C. T. Morita, and M. B. Brenner, “CD1b restricts the response of human CD4CD8 T lymphocytes to a microbial antigen,” Nature, vol. 360, no. 6404, pp. 593–597, 1992. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. M. Beckman, S. A. Porcelli, C. T. Morita, S. M. Behar, S. T. Furlong, and M. B. Brenner, “Recognition of lipid antigen by CD1-restricted αβ+ T cells,” Nature, vol. 372, no. 6507, pp. 691–694, 1994. View at Google Scholar · View at Scopus
  6. N. R. Cohen, S. Garg, and M. B. Brenner, “Chapter 1 antigen presentation by CD1. Lipids, T cells, and NKT cells in microbial immunity,” Advances in Immunology, vol. 102, pp. 1–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Taniguchi and T. Nakayama, “Recognition and function of Vα14 NKT cells,” Seminars in Immunology, vol. 12, no. 6, pp. 543–550, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. Betel, A. Koppal, P. Agius, C. Sander, and C. Leslie, “Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites,” Genome Biology, vol. 11 , article R90, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. W. Kasinrerk, T. Baumruker, O. Majdic, W. Knapp, and H. Stockinger, “CD1 molecule expression on human monocytes induced by granulocyte- macrophage colony-stimulating factor,” Journal of Immunology, vol. 150, no. 2, pp. 579–584, 1993. View at Google Scholar
  10. S. A. Porcelli and R. L. Modlin, “The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids,” Annual Review of Immunology, vol. 17, pp. 297–329, 1999. View at Publisher · View at Google Scholar · View at PubMed
  11. U. E. Schaible, K. Hagens, K. Fischer, H. L. Collins, and S. H. E. Kaufmann, “Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells,” Journal of Immunology, vol. 164, no. 9, pp. 4843–4852, 2000. View at Google Scholar
  12. M. Salio, J. D. Silk, and V. Cerundolo, “Recent advances in processing and presentation of CD1 bound lipid antigens,” Current Opinion in Immunology, vol. 22, no. 1, pp. 81–88, 2010. View at Publisher · View at Google Scholar · View at PubMed
  13. E. M. Beckman, S. A. Porcelli, C. T. Morita, S. M. Behar, S. T. Furlong, and M. B. Brenner, “Recognition of lipid antigen by CD1-restricted αβ T cells,” Nature, vol. 372, no. 6507, pp. 691–694, 1994. View at Google Scholar
  14. S. A. Porcelli, “The CD1 family: a third lineage of antigen-presenting molecules,” Advances in Immunology, vol. 59, pp. 1–98, 1995. View at Google Scholar
  15. S. Stenger, R. J. Mazzaccaro, K. Uyemura et al., “Differential effects of cytolytic T cell subsets on intracellular infection,” Science, vol. 276, no. 5319, pp. 1684–1687, 1997. View at Publisher · View at Google Scholar
  16. P. A. Sieling, M. T. Ochoa, D. Jullien et al., “Evidence for human CD4 T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions,” Journal of Immunology, vol. 164, no. 9, pp. 4790–4796, 2000. View at Google Scholar
  17. Y. Cui, L. Kang, L. Cui, and W. He, “Human γδ T cell Recognition of lipid A is predominately presented by CD1b or CD1c on dendritic cells,” Biology Direct, vol. 4, article 47, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Thoma-Uszynski, S. Stenger, and R. L. Modlin, “CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis,” Journal of Immunology, vol. 165, no. 10, pp. 5773–5779, 2000. View at Google Scholar
  19. M. Brigl and M. B. Brenner, “CD1: antigen presentation and T cell function,” Annual Review of Immunology, vol. 22, pp. 817–890, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. M. S. Vincent, J. E. Gumperz, and M. B. Brenner, “Understanding the function of CD1-restricted T cells,” Nature Immunology, vol. 4, no. 6, pp. 517–523, 2003. View at Publisher · View at Google Scholar · View at PubMed
  21. P. Méndez-Samperio, “Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease,” International Journal of Infectious Diseases, vol. 14, no. 5, pp. e366–e371, 2010. View at Google Scholar
  22. G. De Libero and L. Mori, “Structure and biology of self lipid antigens,” Current Topics in Microbiology and Immunology, vol. 314, pp. 51–72, 2007. View at Publisher · View at Google Scholar
  23. M. M. Blewett, “Lipid autoreactivity in multiple sclerosis,” Medical Hypotheses, vol. 74, no. 3, pp. 433–442, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. C. C. Dascher, K. Hiromatsu, X. Xiong et al., “Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis,” International Immunology, vol. 15, no. 8, pp. 915–925, 2003. View at Publisher · View at Google Scholar
  25. K. Hiromatsu, C. C. Dascher, K. P. LeClair et al., “Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens,” Journal of Immunology, vol. 169, no. 1, pp. 330–339, 2002. View at Google Scholar
  26. K. Felio, H. Nguyen, C. C. Dascher et al., “CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice,” Journal of Experimental Medicine, vol. 206, no. 11, pp. 2497–2509, 2009. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Colmone, S. Li, and C. R. Wang, “Activating transcription factor/cAMP response element binding protein family member regulated transcription of CD1A,” Journal of Immunology, vol. 177, no. 10, pp. 7024–7032, 2006. View at Google Scholar
  28. K. Niwano, M. Arai, N. Koitabashi et al., “Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 1036–1042, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. V. Havelange and R. Garzon, “Micrornas: emerging key regulators of hematopoiesis,” American Journal of Hematology, vol. 85, no. 12, pp. 935–942, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. B. S. Cobb, A. Hertweck, J. Smith et al., “A role for Dicer in immune regulation,” Journal of Experimental Medicine, vol. 203, no. 11, pp. 2519–2527, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. M. A. Lindsay, “microRNAs and the immune response,” Trends in Immunology, vol. 29, no. 7, pp. 343–351, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. Recchiuti, S. Krishnamoorthy, G. Fredman et al., “MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits,” FASEB Journal, vol. 25, no. 2, pp. 544–560, 2011. View at Google Scholar
  33. H. Kuipers, F. M. Schnorfeil, H.-J. Fehling, H. Bartels, and T. Brocker, “Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo,” Journal of Immunology, vol. 185, no. 1, pp. 400–409, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. V. I. D. Ros and G. D. D. Hurst, “Lateral gene transfer between prokaryotes and multicellular eukaryotes: ongoing and significant?” BMC Biology, vol. 7, article 20, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. J. M. DiChiara, L. M. Contreras-Martinez, J. Livny, D. Smith, K. A. McDonough, and M. Belfort, “Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis,” Nucleic Acids Research, vol. 38, no. 12, pp. 4067–4078, 2010. View at Publisher · View at Google Scholar · View at PubMed
  36. T. Akama, K. Suzuki, K. Tanigawa et al., “Whole-genome tiling array analysis of Mycobacterium leprae RNA reveals high expression of pseudogenes and noncoding regions,” Journal of Bacteriology, vol. 191, no. 10, pp. 3321–3327, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. Y. Watanabe, E. Watari, I. Matsunaga et al., “BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components,” Vaccine, vol. 24, no. 29-30, pp. 5700–5707, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. J. Liu, V. Tran, A. S. Leung, D. C. Alexander, and B. Zhu, “BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy,” Human Vaccines, vol. 5, no. 2, pp. 70–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. F. Barker, M. J. Brennan, P. K. Rosenstein, and J. C. Sadoff, “Tuberculosis vaccine research: the impact of immunology,” Current Opinion in Immunology, vol. 21, no. 3, pp. 331–338, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. L. J. Alderwick, H. L. Birch, A. K. Mishra, L. Eggeling, and G. S. Besra, “Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1325–1328, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. D. B. Moody, D. C. Young, T. Y. Cheng et al., “T cell activation by lipopeptide antigens,” Science, vol. 303, no. 5657, pp. 527–531, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. D. B. Moody, T. Ulrichs, W. Mühlecker et al., “CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection,” Nature, vol. 404, no. 6780, pp. 884–888, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. Gilleron, S. Stenger, Z. Mazorra et al., “Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis,” Journal of Experimental Medicine, vol. 199, no. 5, pp. 649–659, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. G. De Libero and L. Mori, “Recognition of lipid antigens by T cells,” Nature Reviews Immunology, vol. 5, no. 6, pp. 485–496, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. Guiard, A. Collmann, L. F. Garcia-Alles et al., “Fatty acyl structures of Mycobacterium tuberculosis sulfoglycolipid govern T cell response,” Journal of Immunology, vol. 182, no. 11, pp. 7030–7037, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. A. Kasmar, I. Van Rhijn, and D. B. Moody, “The evolved functions of CD1 during infection,” Current Opinion in Immunology, vol. 21, no. 4, pp. 397–403, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. P. A. Sieling, D. Jullien, M. Dahlem et al., “CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity,” Journal of Immunology, vol. 162, no. 3, pp. 1851–1858, 1999. View at Google Scholar · View at Scopus
  48. L. F. Barker, M. J. Brennan, P. K. Rosenstein, and J. C. Sadoff, “Tuberculosis vaccine research: the impact of immunology,” Current Opinion in Immunology, vol. 21, no. 3, pp. 331–338, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. P. A. Sieling, J. B. Torrelles, S. Stenger et al., “The human CD1-restricted T cell repertoire is limited to cross-reactive antigens: implications for host responses against immunologically related pathogens,” Journal of Immunology, vol. 174, no. 5, pp. 2637–2644, 2005. View at Google Scholar · View at Scopus
  50. T. Ulrichs, D. B. Moody, E. Grant, S. H. E. Kaufmann, and S. A. Porcelli, “T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection,” Infection and Immunity, vol. 71, no. 6, pp. 3076–3087, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Chen, B. Zhou, M. Li et al., “CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease,” Clinical Immunology, vol. 123, no. 1, pp. 50–59, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. S. Vincent, X. Xiong, E. P. Grant, W. Peng, and M. B. Brenner, “CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens,” Journal of Immunology, vol. 175, no. 10, pp. 6344–6351, 2005. View at Google Scholar · View at Scopus
  53. T. K. A. Nguyen, A. P. Koets, W. J. Santema, W. van Eden, V. P. M. G. Rutten, and I. Van Rhijn, “The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle,” Vaccine, vol. 27, no. 35, pp. 4818–4825, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. S. H. E. Kaufmann, “Protection against tuberculosis: cytokines, T cells, and macrophages,” Annals of the Rheumatic Diseases, vol. 61, no. 2, pp. ii54–ii58, 2002. View at Google Scholar · View at Scopus
  55. J. Lee and H. Kornfeld, “Interferon-γ regulates the death of M. tuberculosis-infected macrophages,” Journal of Cell Death, vol. 3, pp. 1–11, 2010. View at Google Scholar
  56. A. Baena and S. A. Porcelli, “Evasion and subversion of antigen presentation by Mycobacterium tuberculosis,” Tissue Antigens, vol. 74, no. 3, pp. 189–204, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. González-Juarrero and M. P. O'Sullivan, “Optimization of inhaled therapies for tuberculosis: the role of macrophages and dendritic cells,” Tuberculosis, vol. 91, no. 1, pp. 86–92, 2011. View at Publisher · View at Google Scholar · View at PubMed
  58. L. S. Meena and T. Rajni, “Survival mechanisms of pathogenic Mycobacterium tuberculosis H37 Rv,” FEBS Journal, vol. 277, no. 11, pp. 2416–2427, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. L. Lang and A. Glatman-Freedman, “Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?” Infection and Immunity, vol. 74, no. 2, pp. 803–809, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. R. Jayachandran, V. Sundaramurthy, B. Combaluzier et al., “Survival of Mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin,” Cell, vol. 130, no. 1, pp. 37–50, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. F. Winau, S. H. E. Kaufmann, and U. E. Schaible, “Apoptosis paves the detour path for CD8T cell activation against intracellular bacteria,” Cellular Microbiology, vol. 6, no. 7, pp. 599–607, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. L. Danelishvili, Y. Yamazaki, J. Selker, and L. E. Bermudez, “Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis,” PLoS ONE, vol. 5, no. 5, Article ID e10474, 2010. View at Publisher · View at Google Scholar · View at PubMed
  63. S. Stenger, K. R. Niazi, and R. L. Modlin, “Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis,” Journal of Immunology, vol. 161, no. 7, pp. 3582–3588, 1998. View at Google Scholar · View at Scopus
  64. S. P. Prete, G. Girolomoni, A. Giuliani et al., “Limited introduction of CD1b expression by BCG in human adherent mononuclear cells is mediated by GM-CSF,” Journal of Chemotherapy, vol. 12, supplement 6, p. 146, 2000. View at Google Scholar
  65. C. Roura-Mir, L. Wang, T. Y. Cheng et al., “Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2,” Journal of Immunology, vol. 175, no. 3, pp. 1758–1766, 2005. View at Google Scholar · View at Scopus
  66. P. A. Videira, F. M. Calais, M. Correia et al., “Efficacy of Bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines,” Urology, vol. 74, no. 4, pp. 944–950, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. A. Miranda, T. P. Amadeu, G. Schueler et al., “Increased Langerhans cell accumulation after mycobacterial stimuli,” Histopathology, vol. 51, no. 5, pp. 649–656, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. P. Rajashree, G. Krishnan, and S. D. Das, “Impaired phenotype and function of monocyte derived dendritic cells in pulmonary tuberculosis,” Tuberculosis, vol. 89, no. 1, pp. 77–83, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. S. P. Prete, A. Giuliani, E. Iona et al., “Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes,” Journal of Chemotherapy, vol. 13, no. 1, pp. 52–58, 2001. View at Google Scholar · View at Scopus
  70. A. Giuliani, S. P. Prete, G. Graziani et al., “Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells,” Infection and Immunity, vol. 69, no. 12, pp. 7461–7470, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. S. Mariotti, R. Teloni, E. Iona et al., “Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells,” European Journal of Immunology, vol. 32, no. 11, pp. 3050–3058, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. M. C. Gagliardi, R. Teloni, S. Mariotti et al., “Bacillus Calmette-Guérin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: Implication for its efficacy as a vaccine preventing tuberculosis,” Vaccine, vol. 22, no. 29-30, pp. 3848–3857, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. A. Martino, A. Sacchi, E. Volpe et al., “Non-pathogenic Mycobacterium smegmatis induces the differentiation of human monocytes directly into fully mature dendritic cells,” Journal of Clinical Immunology, vol. 25, no. 4, pp. 365–375, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. S. P. Prete, A. Giuliani, S. D'Atri et al., “BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression,” International Immunopharmacology, vol. 7, no. 3, pp. 321–332, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. M. C. Gagliardi, R. Teloni, F. Giannoni et al., “Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells,” Infection and Immunity, vol. 77, no. 11, pp. 4947–4952, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. M. E. Remoli, E. Giacomini, E. Petruccioli et al., “Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10,” Immunology and Cell Biology. 31 August 2010. View at Publisher · View at Google Scholar · View at PubMed
  77. S. B. Jung, C. H. Song, C. S. Yang et al., “Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-α and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis,” Journal of Clinical Immunology, vol. 25, no. 5, pp. 482–490, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. N. Reiling, A. Blumenthal, H. D. Flad, M. Ernst, and S. Ehlers, “Mycobacteria-induced TNF-α and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity,” Journal of Immunology, vol. 167, no. 6, pp. 3339–3345, 2001. View at Google Scholar · View at Scopus
  79. C. H. Song, J. S. Lee, S. H. Lee et al., “Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor-α, interleukin-10, and monocyte chemotactic protein-1 by Mycobacterium tuberculosis H37Rv-infected human monocytes,” Journal of Clinical Immunology, vol. 23, no. 3, pp. 194–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Méndez-Samperio, A. Trejo, and A. Pérez, “Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells,” Cellular Immunology, vol. 251, no. 1, pp. 37–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. C. D. Souza, O. A. Evanson, and D. J. Weiss, “Mitogen activated protein kinase pathway is an important component of the anti-inflammatory response in Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes,” Microbial Pathogenesis, vol. 41, no. 2-3, pp. 59–66, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. B. K. W. Cheung, D. C. W. Lee, J. C. B. Li, YU. L. Lau, and A. S. Y. Lau, “A role for double-stranded RNA-activated protein kinase PKR in Mycobacterium-induced cytokine expression,” Journal of Immunology, vol. 175, no. 11, pp. 7218–7225, 2005. View at Google Scholar · View at Scopus
  83. M. M. P. Chan, B. K. W. Cheung, J. C. B. Li, L. L. Y. Chan, and A. S. Y. Lau, “A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction,” Journal of Leukocyte Biology, vol. 86, no. 2, pp. 283–291, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. S. Nair, P. A. Ramaswamy, S. Ghosh et al., “The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage,” Journal of Immunology, vol. 183, no. 10, pp. 6269–6281, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. L. Balboa, M. M. Romero, N. Yokobori et al., “Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile,” Immunology and Cell Biology, vol. 88, no. 7, pp. 716–726, 2010. View at Publisher · View at Google Scholar · View at PubMed
  86. J. L. Strominger, “An alternative path for antigen presentation: group 1 CD1 proteins,” Journal of Immunology, vol. 184, no. 7, pp. 3303–3305, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. A. Shamshiev, A. Donda, T. I. Prigozy et al., “The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides,” Immunity, vol. 13, no. 2, pp. 255–264, 2000. View at Google Scholar · View at Scopus
  88. V. Manolova, M. Kistowska, S. Paoletti et al., “Functional CD1a is stabilized by exogenous lipids,” European Journal of Immunology, vol. 36, no. 5, pp. 1083–1092, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. M. Cernadas, M. Cavallari, G. Watts, L. Mori, G. De Libero, and M. B. Brenner, “Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens,” Journal of Immunology, vol. 184, no. 3, pp. 1235–1241, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. M. Sugita, N. van der Wel, R. A. Rogers, P. J. Peters, and M. B. Brenner, “CD1c molecules broadly survey the endocytic system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8445–8450, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. D. Zhou, C. Cantu III, Y. Sagiv et al., “Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins,” Science, vol. 303, no. 5657, pp. 523–527, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. P. van den Elzen, S. Garg, L. León et al., “Apolipoprotein-mediated pathways of lipid antigen presentation,” Nature, vol. 437, no. 7060, pp. 906–910, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. H. de la Salle, S. Mariotti, C. Angenieux et al., “Immunology: assistance of microbial glycolipid antigen processing by CD1e,” Science, vol. 310, no. 5752, pp. 1321–1324, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. S. Tourne, B. Maitre, A. Collmann et al., “Cutting edge: a naturally occurring mutation in CD1e impairs lipid antigen presentation,” Journal of Immunology, vol. 180, no. 6, pp. 3642–3646, 2008. View at Google Scholar · View at Scopus
  95. M. Relloso, T. Y. Cheng, J. S. Im et al., “pH-Dependent Interdomain Tethers of CD1b Regulate Its Antigen Capture,” Immunity, vol. 28, no. 6, pp. 774–786, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. E. Shinya, A. Owaki, M. Shimizu et al., “Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells,” Virology, vol. 326, no. 1, pp. 79–89, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. M. G. Quaranta, E. Tritarelli, L. Giordani, and M. Viora, “HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4+ T cell activation,” Experimental Cell Research, vol. 275, no. 2, pp. 243–254, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. R. D. Wiley and S. Gummuluru, “Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 738–743, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. A. Sacchi, G. Cappelli, C. Cairo et al., “Differentiation of monocytes into CD1a- dendritic cells correlates with disease progression in HIV-infected patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, no. 5, pp. 519–528, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. M. Makino, S. I. Wakamatsu, S. Shimokubo, N. Arima, and M. Baba, “Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia,” Virology, vol. 274, no. 1, pp. 140–148, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. B. Ensoli, L. Buonaguro, G. Barillari et al., “Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation,” Journal of Virology, vol. 67, no. 1, pp. 277–287, 1993. View at Google Scholar · View at Scopus
  102. K. Gee, J. B. Angel, S. Mishra, M. A. Blahoianu, and A. Kumar, “IL-10 regulation by HIV-tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPIC and Sp-1 and CREB-1 transcription factors,” Journal of Immunology, vol. 178, no. 2, pp. 798–807, 2007. View at Google Scholar · View at Scopus
  103. T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser, “Effect of interleukin-10 on dendritic cell maturation and function,” European Journal of Immunology, vol. 27, no. 5, pp. 1229–1235, 1997. View at Google Scholar · View at Scopus
  104. C. Buelens, V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems, “Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor,” European Journal of Immunology, vol. 27, no. 3, pp. 756–762, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. P. Allavena, L. Piemonti, D. Longoni et al., “IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages,” European Journal of Immunology, vol. 28, no. 1, pp. 359–369, 1998. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Gerlini, A. Tun-Kyi, C. Dudli, G. Burg, N. Pimpinelli, and F. O. Nestle, “Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions,” American Journal of Pathology, vol. 165, no. 6, pp. 1853–1863, 2004. View at Google Scholar · View at Scopus
  107. K. A. Nahmod, M. E. Vermeulen, S. Raiden et al., “Control of dendritic cell differentiation by angiotensin II,” The FASEB Journal, vol. 17, no. 3, pp. 491–493, 2003. View at Google Scholar · View at Scopus
  108. A. Tanaka, K. Minoguchi, K. T. R. Samson et al., “Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma,” Clinical and Experimental Allergy, vol. 37, no. 7, pp. 1083–1089, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. E. M. Knijff, C. Ruwhof, H. J. De Wit et al., “Monocyte-derived dendritic cells in bipolar disorder,” Biological Psychiatry, vol. 59, no. 4, pp. 317–326, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. K.-J. Liu, Y.-L. Lee, Y.-Y. Yang et al., “Modulation of the development of human monocyte-derived dendritic cells by lithium chloride,” Journal of Cellular Physiology, vol. 226, no. 2, pp. 424–433, 2011. View at Publisher · View at Google Scholar · View at PubMed
  111. J. Komi and O. Lassila, “Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells,” Blood, vol. 95, no. 9, pp. 2875–2882, 2000. View at Google Scholar · View at Scopus
  112. G. M. Möller, S. E. Overbeek, C. G. Van Helden-Meeuwsen et al., “Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids,” Clinical and Experimental Allergy, vol. 26, no. 5, pp. 517–524, 1996. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Q. Xia, R. Peng, F. Beato, and M. J. Clare-Salzler, “Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity,” Scandinavian Journal of Immunology, vol. 62, no. 1, pp. 45–54, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. E. S. Mainali and J. G. Tew, “Dexamethasone selectively inhibits differentiation of cord blood stem cell derived-dendritic cell (DC) precursors into immature DCs,” Cellular Immunology, vol. 232, no. 1-2, pp. 127–136, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. E. S. Mainali, T. Kikuchi, and J. G. Tew, “Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood,” Pediatric Research, vol. 58, no. 1, pp. 125–131, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. G. T. Verhoeven, J. M. W. Van Haarst, H. J. De Wit, P. J. Simons, H. C. Hoogsteden, and H. A. Drexhage, “Glucocorticoids hamper the ex vivo maturation of lung dendritic cells from their low autofluorescent precursors in the human bronchoalveolar lavage: decreases in allostimulatory capacity and expression of CD80 and CD86,” Clinical and Experimental Immunology, vol. 122, no. 2, pp. 232–240, 2000. View at Publisher · View at Google Scholar
  117. A. Giuliani, S. A. Porcelli, L. Tentori et al., “Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen,” Life Sciences, vol. 63, no. 12, pp. 985–994, 1998. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Tentori, G. Graziani, S. A. Porcelli et al., “Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 3, pp. 550–554, 1998. View at Google Scholar · View at Scopus
  119. A. Giuliani, L. Tentori, R. Pepponi et al., “Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3-azido-3-deoxythymidine,” Pharmacological Research, vol. 35, no. 2, pp. 135–140, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. G. F. Lu, F. A. Tang, P. Y. Zheng, P. C. Yang, and Y. M. Qi, “Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B,” World Journal of Gastroenterology, vol. 14, no. 10, pp. 1617–1621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. Y. J. Chen, K. S. C. Chao, Y. C. Yang, M. L. Hsu, C. P. Lin, and Y. Y. Chen, “Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells,” Immunopharmacology and Immunotoxicology, vol. 31, no. 3, pp. 499–508, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. E. den Dekker, S. Grefte, T. Huijs et al., “Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells,” Journal of Immunology, vol. 180, no. 6, pp. 3680–3688, 2008. View at Google Scholar · View at Scopus
  123. A. Nencioni, J. Beck, D. Werth et al., “Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity,” Clinical Cancer Research, vol. 13, no. 13, pp. 3933–3941, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. C. R. Nascimento, C. G. Freire-de-Lima, A. da Silva de Oliveira, F. D. Rumjanek, and V. M. Rumjanek, “The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells,” Immunobiology, vol. 216, no. 3, pp. 275–284, 2011. View at Publisher · View at Google Scholar · View at PubMed
  125. K. J. Smith, S. Hamza, and H. Skelton, “Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern,” Clinical and Experimental Dermatology, vol. 29, no. 5, pp. 505–512, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. Y. Q. Shu and Y. Gu, “The effect ofdendritic cells activated byOK-432and pulsed with antigens oncytokine induced killers,” Biomedicine and Pharmacotherapy, vol. 60, no. 4, pp. 156–160, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  127. Z. Y. Wang, A. Morinobu, S. Kawano, J. Saegusa, B. Wang, and S. Kumagai, “Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes,” Clinical and Experimental Rheumatology, vol. 20, no. 5, pp. 683–688, 2002. View at Google Scholar · View at Scopus
  128. M. Ruggieri, C. Pica, A. Lia et al., “Combination treatment of glatiramer acetate and minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients,” Journal of Neuroimmunology, vol. 197, no. 2, pp. 140–146, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. Y. Hussein, A. Sanna, M. Söderström, H. Link, and Y. M. Huang, “Multiple sclerosis: expression of CDIa and production of IL-12 p70 and IFN-γ by blood mononuclear cells in patients on combination therapy with IFN-β and glatiramer acetate compared to monotherapy with IFN-β,” Multiple Sclerosis, vol. 10, no. 1, pp. 16–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. Y. Hussien, A. Sanna, M. Söderström, H. Link, and YU. M. Huang, “Glatiramer acetate and IFN-β act on dendritic cells in multiple sclerosis,” Journal of Neuroimmunology, vol. 121, no. 1-2, pp. 102–110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. N. H. R. Litjens, M. Rademaker, B. Ravensbergen, H. B. Thio, J. T. Van Dissel, and P. H. Nibbering, “Effects of monomethylfumarate on dendritic cell differentiation,” British Journal of Dermatology, vol. 154, no. 2, pp. 211–217, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. F. S. Kalthoff, J. Chung, P. Musser, and A. Stuetz, “Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids,” Clinical and Experimental Immunology, vol. 133, no. 3, pp. 350–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Simon, E. Vassina, S. Yousefi, L. R. Braathen, and H. U. Simon, “Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment,” Allergy, vol. 60, no. 7, pp. 944–951, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. P. Monti, A. Mercalli, B. E. Leone, D. C. Valerio, P. Allavena, and L. Piemonti, “Rapamycin impairs antigen uptake of human dendritic cells,” Transplantation, vol. 75, no. 1, pp. 137–145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Chen, C. Yang, N. Jin et al., “Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells,” International Immunopharmacology, vol. 7, no. 8, pp. 1102–1110, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. J. Cos, T. Villalba, R. Parra et al., “FK506 in the maturation of dendritic cells,” Haematologica, vol. 87, no. 7, pp. 679–687, 2002. View at Google Scholar · View at Scopus
  137. A. Wollenberg, S. Sharma, D. von Bubnoff, E. Geiger, J. Haberstok, and T. Bieber, “Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 107, no. 3, pp. 519–525, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. K. Shimizu, S. I. Fujii, K. Fujimoto, K. Kawa, A. Yamada, and F. Kawano, “Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses,” Journal of Leukocyte Biology, vol. 68, no. 5, pp. 633–640, 2000. View at Google Scholar · View at Scopus
  139. K. J. Zhu, Q. Y. Shen, H. Cheng, X. H. Mao, LI. M. Lao, and G. L. Hao, “Triptolide affects the differentiation, maturation and function of human dendritic cells,” International Immunopharmacology, vol. 5, no. 9, pp. 1415–1426, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. A. Del Prete, P. Zaccagnino, M. Di Paola et al., “Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1443–1451, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. R. van de Ven, M. C. de Jong, A. W. Reurs et al., “Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation,” Journal of Immunology, vol. 176, no. 9, pp. 5191–5198, 2006. View at Google Scholar · View at Scopus
  142. C. Bedini, F. Nasorri, G. Girolomoni, O. De Pità, and A. Cavani, “Antitumour necrosis factor-α chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function,” British Journal of Dermatology, vol. 157, no. 2, pp. 249–258, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. B. Bufan, S. Mojsilović, D. Vučićević et al., “Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro,” International Immunopharmacology, vol. 9, no. 7-8, pp. 910–917, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. U. Švajger, A. Vidmar, and M. Jeras, “Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4,” International Immunopharmacology, vol. 8, no. 7, pp. 997–1005, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  145. A. Kaser, D. L. Hava, S. K. Dougan et al., “Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules,” European Journal of Immunology, vol. 38, no. 8, pp. 2351–2359, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. V. Fernández-Ruiz, A. González, and N. López-Moratalla, “Effect of nitric oxide in the differentiation of human monocytes to dendritic cells,” Immunology Letters, vol. 93, no. 1, pp. 87–95, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. P. López, C. Gutiérrez, A. Suárez et al., “IFNα treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression,” Clinical Immunology, vol. 129, no. 2, pp. 350–359, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. H. Bartosik-Psujek, J. Tabarkiewicz, K. Pocinska, S. Radej, Z. Stelmasiak, and J. Rolinski, “Immunomodulatory effects of IFN-β and lovastatin on immunophenotype of monocyte-derived dendritic cells in multiple sclerosis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 58, no. 4, pp. 313–319, 2010. View at Publisher · View at Google Scholar · View at PubMed
  149. M. Sioud and Y. Fløisand, “TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response,” European Journal of Immunology, vol. 37, no. 10, pp. 2834–2846, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  150. S. Appel, A. Rupf, M. M. Weck et al., “Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-κB and Akt signaling pathways,” Clinical Cancer Research, vol. 11, no. 5, pp. 1928–1940, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. S. Appel, A. M. Boehmler, F. Grünebach et al., “Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells,” Blood, vol. 103, no. 2, pp. 538–544, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  152. M. M. Hipp, N. Hilf, S. Walter et al., “Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses,” Blood, vol. 111, no. 12, pp. 5610–5620, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. M. Mohty, S. Morbelli, D. Isnardon et al., “All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells,” British Journal of Haematology, vol. 122, no. 5, pp. 829–836, 2003. View at Publisher · View at Google Scholar · View at Scopus
  154. Y. Wada, T. Hisamatsu, N. Kamada, S. Okamoto, and T. Hibi, “Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells,” Inflammatory Bowel Diseases, vol. 15, no. 10, pp. 1548–1556, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. P. Schütt, U. Buttkereit, D. Brandhorst et al., “In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment,” Cancer Immunology, Immunotherapy, vol. 54, no. 5, pp. 506–512, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. S. J. Oliver, T. Kikuchi, J. G. Krueger, and G. Kaplan, “Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement,” Clinical Immunology, vol. 102, no. 3, pp. 225–236, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  157. T. R. Coven, F. P. Murphy, P. Gilleaudeau, I. Cardinale, and J. G. Krueger, “Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris: evidence that epidermal immunocytes are direct therapeutic targets,” Archives of Dermatology, vol. 134, no. 10, pp. 1263–1268, 1998. View at Publisher · View at Google Scholar · View at Scopus
  158. M. O. Canning, K. Grotenhuis, H. J. de Wit, and H. A. Drexhage, “Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells,” European Journal of Endocrinology, vol. 143, no. 5, pp. 687–695, 2000. View at Google Scholar · View at Scopus
  159. M. Takei, A. Umeyama, and S. Arihara, “T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization,” European Journal of Pharmacology, vol. 537, no. 1–3, pp. 190–199, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. M. Takei, A. Umeyama, and S. Arihara, “Epicubenol and Ferruginol induce DC from human monocytes and differentiate IL-10-producing regulatory T cells in vitro,” Biochemical and Biophysical Research Communications, vol. 337, no. 2, pp. 730–738, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  161. M. Takei, A. Umeyama, S. Arihara, and H. Matsumoto, “Effect of piceatannol in human monocyte-derived dendritic cells in vitro,” Journal of Pharmaceutical Sciences, vol. 94, no. 5, pp. 974–982, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  162. M. Takei, E. Tachikawa, H. Hasegawa, and J.-J. Lee, “Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization,” Biochemical Pharmacology, vol. 68, no. 3, pp. 441–452, 2004. View at Publisher · View at Google Scholar · View at PubMed
  163. M. O. Canning, K. Grotenhuis, H. de Wit, C. Ruwholf, and H. A. Drexhage, “1-α,25-dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes,” European Journal of Endocrinology, vol. 145, no. 3, pp. 351–357, 2001. View at Google Scholar · View at Scopus
  164. A. Berer, J. Stöckl, O. Majdic et al., “1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro,” Experimental Hematology, vol. 28, no. 5, pp. 575–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  165. H. Bartosik-Psujek, J. Tabarkiewicz, K. Pocinska, Z. Stelmasiak, and J. Rolinski, “Immunomodulatory effects of vitamin D3 on monocyte-derived dendritic cells in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 12, pp. 1513–1516, 2010. View at Publisher · View at Google Scholar · View at PubMed
  166. A. W. Pedersen, K. Holmstrøm, S. S. Jensen et al., “Phenotypic and functional markers for 1α,25-dihydroxyvitamin D3 -modified regulatory dendritic cells,” Clinical and Experimental Immunology, vol. 157, no. 1, pp. 48–59, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  167. K. Zhu, R. Gläser, and U. Mrowietz, “Vitamin D3 and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells,” Biochemical and Biophysical Research Communications, vol. 297, no. 5, pp. 1211–1217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  168. L. Piemonti, P. Monti, M. Sironi et al., “Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells,” Journal of Immunology, vol. 164, no. 9, pp. 4443–4451, 2000. View at Google Scholar · View at Scopus
  169. J. Reichrath, S. M. Müller, A. Kerber, H. P. Baum, and F. A. Bahmer, “Biologic effects of topical calcipotriol (MC903) treatment in psoriatic skin,” Journal of the American Academy of Dermatology, vol. 36, no. 1, pp. 19–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  170. M. Herfs, L. Herman, P. Hubert et al., “High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells,” Cancer Immunology, Immunotherapy, vol. 58, no. 4, pp. 603–614, 2009. View at Publisher · View at Google Scholar · View at PubMed
  171. J. J. Lee, M. Takei, S. Hori et al., “The role of PGE2 in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?” Stem Cells, vol. 20, no. 5, pp. 448–459, 2002. View at Google Scholar · View at Scopus
  172. P. Kaliński, C. M. U. Hilkens, A. Snijders, F. G. M. Snijdewint, and M. L. Kapsenberg, “IL-12-deficient dendritic cells, generated in the presence of prostaglandin E, promote type 2 cytokine production in maturing human naive T helper cells,” Journal of Immunology, vol. 159, no. 1, pp. 28–35, 1997. View at Google Scholar · View at Scopus
  173. P. Kaliński, C. M. U. Hilkens, A. Snijders, F. G. M. Snijdewint, and M. L. Kapsenberg, “Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses,” Advances in Experimental Medicine and Biology, vol. 417, pp. 363–367, 1997. View at Google Scholar · View at Scopus
  174. C. C. Sombroek, A. G. M. Stam, A. J. Masterson et al., “Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation,” Journal of Immunology, vol. 168, no. 9, pp. 4333–4343, 2002. View at Google Scholar · View at Scopus
  175. A. Nencioni, K. Lauber, F. Grünebach et al., “Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-γ-independent mechanism: regulation by inflammatory and T cell-derived stimuli,” Experimental Hematology, vol. 30, no. 9, pp. 1020–1028, 2002. View at Publisher · View at Google Scholar · View at Scopus
  176. N. Katoh, F. Soga, T. Nara et al., “Effect of serotonin on the differentiation of human monocytes into dendritic cells,” Clinical and Experimental Immunology, vol. 146, no. 2, pp. 354–361, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  177. L. G. Radvanyi, A. Banerjee, M. Weir, and H. Messner, “Low levels of interferon-α induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells,” Scandinavian Journal of Immunology, vol. 50, no. 5, pp. 499–509, 1999. View at Publisher · View at Google Scholar · View at Scopus
  178. S. L. Pogue, B. T. Preston, J. Stalder, C. R. Bebbington, and P. M. Cardarelli, “The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells,” Journal of Interferon and Cytokine Research, vol. 24, no. 2, pp. 131–139, 2004. View at Publisher · View at Google Scholar · View at PubMed
  179. M. Merad, E. Angevin, J. Wolfers et al., “Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-α plus IL-2 and IL-12),” Journal of Immunotherapy, vol. 23, no. 3, pp. 369–378, 2000. View at Publisher · View at Google Scholar
  180. Y. M. Huang, S. Adikari, U. Båve, A. Sanna, and G. Alm, “Multiple sclerosis: Interferon-beta induces CD123+BDCA2 dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production,” Journal of Neuroimmunology, vol. 158, no. 1-2, pp. 204–212, 2005. View at Publisher · View at Google Scholar · View at PubMed
  181. Y. C. Q. Zang, S. M. Skinner, R. R. Robinson et al., “Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis,” Multiple Sclerosis, vol. 10, no. 5, pp. 499–506, 2004. View at Publisher · View at Google Scholar
  182. E. J. Bartholomé, F. Willems, A. Crusiaux, K. Thielemans, L. Schandene, and M. Goldman, “IFN-β interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion,” Journal of Interferon and Cytokine Research, vol. 19, no. 5, pp. 471–478, 1999. View at Publisher · View at Google Scholar · View at PubMed
  183. Y. Hussein, A. Sanna, M. Söderström, H. Link, and Y. -M. Huang, “Multiple sclerosis: expression of CDIa and production of IL-12 p70 and IFN-γ by blood mononuclear cells in patients on combination therapy with IFN-β and glatiramer acetate compared to monotherapy with IFN-β,” Multiple Sclerosis, vol. 10, no. 1, pp. 16–25, 2004. View at Publisher · View at Google Scholar
  184. B. L. McRae, T. Nagai, R. T. Semnani, J. M. Van Seventer, and G. A. Van Seventer, “Interferon-α and -β inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14 precursors,” Blood, vol. 96, no. 1, pp. 210–217, 2000. View at Google Scholar
  185. Y. Hussien, A. Sanna, M. Söderström, H. Link, and Y. M. Huang, “Glatiramer acetate and IFN-β act on dendritic cells in multiple sclerosis,” Journal of Neuroimmunology, vol. 121, no. 1-2, pp. 102–110, 2001. View at Publisher · View at Google Scholar
  186. Y. Rongcun, H. Maes, M. Corsi, F. Dellner, T. Wen, and R. Kiessling, “Interferon γ impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1a, CD80 and CD4,” Cytokine, vol. 10, no. 10, pp. 747–755, 1998. View at Publisher · View at Google Scholar · View at PubMed
  187. Y. Delneste, P. Charbonnier, N. Herbault et al., “Interferon- switches monocyte differentiation from dendritic cells to macrophages,” Blood, vol. 101, no. 1, pp. 143–150, 2003. View at Google Scholar
  188. M. Makino, Y. Maeda, T. Mukai, and S. H. E. Kaufmann, “Impaired maturation and function of dendritic cells by mycobacteria through IL-1β,” European Journal of Immunology, vol. 36, no. 6, pp. 1443–1452, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  189. N. Gupta, A. P. Barhanpurkar, G. B. Tomar et al., “IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage,” Journal of Immunology, vol. 185, no. 4, pp. 2261–2272, 2010. View at Publisher · View at Google Scholar · View at PubMed
  190. K. Yamamura, K. Ohishi, N. Katayama et al., “Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor α-positive and -negative human hematopoietic progenitors,” Cancer Science, vol. 98, no. 10, pp. 1597–1603, 2007. View at Publisher · View at Google Scholar · View at PubMed
  191. A. Encabo, P. Solves, E. Mateu, P. Sepúlveda, F. Carbonell-Uberos, and M. D. Miñana, “Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3,” Stem Cells, vol. 22, no. 5, pp. 725–740, 2004. View at Google Scholar · View at Scopus
  192. Z. Yu, W. Liu, D. Liu, and LI. Fan, “The regulatory role of Hyper-IL-6 in the differentiation of myeloid and erythroid progenitors derived from human cord blood,” Cellular Immunology, vol. 241, no. 1, pp. 32–37, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  193. M. Ratta, F. Fagnoni, A. Curti et al., “Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6,” Blood, vol. 100, no. 1, pp. 230–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. P. Chomarat, J. Banchereau, J. Davoust, and A. K. Palucka, “IL-6 switches the differentiation of monocytes from dendritic cells to macrophages,” Nature Immunology, vol. 1, no. 6, pp. 510–514, 2000. View at Google Scholar · View at Scopus
  195. K. Asadullah, M. Friedrich, S. Hanneken et al., “Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings,” Journal of Investigative Dermatology, vol. 116, no. 5, pp. 721–727, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  196. D. Longoni, L. Piemonti, S. Bernasconi, A. Mantovani, and P. Allavena, “Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells,” International Journal of Clinical and Laboratory Research, vol. 28, no. 3, pp. 162–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  197. P. Allavena, L. Piemonti, D. Longoni et al., “IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages,” European Journal of Immunology, vol. 28, no. 1, pp. 359–369, 1998. View at Google Scholar
  198. K. Sato, H. Nagayama, K. Tadokoro, T. Juji, and T. A. Takahashi, “Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells,” Experimental Hematology, vol. 27, no. 2, pp. 326–336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  199. C. Q. Xia and K. J. Kao, “Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells,” International Immunology, vol. 15, no. 8, pp. 1007–1015, 2003. View at Publisher · View at Google Scholar · View at Scopus
  200. E. Riedl, J. Stöckl, O. Majdic, C. Scheinecker, W. Knapp, and H. Strobl, “Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation,” Blood, vol. 96, no. 13, pp. 4276–4284, 2000. View at Google Scholar · View at Scopus
  201. Y. L. Lin, Y. C. Liang, and B. L. Chiang, “Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells,” Journal of Leukocyte Biology, vol. 82, no. 6, pp. 1473–1480, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  202. C. L. Miller-Graziano, A. De, K. Laudanski, T. Herrmann, and S. Bandyopadhyay, “HSP27: an anti-inflammatory and immunomodulatory stress protein acting to dampen immune function,” Novartis Foundation Symposium, vol. 291, pp. 196–208, 2008. View at Google Scholar · View at Scopus
  203. K. Laudanski, A. De, and C. Miller-Graziano, “Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells,” European Journal of Immunology, vol. 37, no. 10, pp. 2812–2824, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  204. E. A. Laborde, S. Vanzulli, M. Beigier-Bompadre et al., “Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells,” Journal of Immunology, vol. 179, no. 1, pp. 673–681, 2007. View at Google Scholar · View at Scopus
  205. L. P. Rennalls, T. Seidl, J. M. G. Larkin et al., “The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells,” Immunology, vol. 129, no. 4, pp. 610–619, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  206. S. Buisson and F. Triebel, “LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors,” Immunology, vol. 114, no. 3, pp. 369–374, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  207. P. Gogolak, B. Rethi, I. Szatmari et al., “Differentiation of CD1a+ and CD1a monocyte-derived dendritic cells is biased by lipid environment and PPARγ,” Blood, vol. 109, no. 2, pp. 643–652, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  208. A. Martino, E. Volpe, and P. M. Baldini, “The influence of lysophosphatidic acid on the immunophenotypic differentiation of human monocytes into dendritic cells,” Haematologica, vol. 91, no. 9, pp. 1273–1274, 2006. View at Google Scholar · View at Scopus
  209. S. Blüml, G. Zupkovitz, S. Kirchberger et al., “Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids,” Blood, vol. 114, no. 27, pp. 5481–5489, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  210. L. Li, S. P. Li, J. Min, and L. Zheng, “Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells,” Immunology Letters, vol. 114, no. 1, pp. 38–45, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  211. C. Menetrier-Caux, G. Montmain, M. C. Dieu et al., “Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony- stimulating factor,” Blood, vol. 92, no. 12, pp. 4778–4791, 1998. View at Google Scholar · View at Scopus
  212. J. M. Motta, C. R. Nascimento, and V. M. Rumjanek, “Leukemic cell products down-regulate human dendritic cell differentiation,” Cancer Immunology, Immunotherapy, vol. 59, no. 11, pp. 1645–1653, 2010. View at Publisher · View at Google Scholar · View at PubMed
  213. G. Gerlini, A. Tun-Kyi, C. Dudli, G. Burg, N. Pimpinelli, and F. O. Nestle, “Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions,” American Journal of Pathology, vol. 165, no. 6, pp. 1853–1863, 2004. View at Google Scholar · View at Scopus
  214. O. Berthier-Vergnes, M. Gaucherand, J. Péguet-Navarro et al., “Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells,” British Journal of Cancer, vol. 85, no. 12, pp. 1944–1951, 2001. View at Google Scholar · View at Scopus
  215. C. C. Sombroek, A. G. M. Stam, A. J. Masterson et al., “Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation,” Journal of Immunology, vol. 168, no. 9, pp. 4333–4343, 2002. View at Google Scholar · View at Scopus
  216. D. Giordano, D. M. Magaletti, E. A. Clark, and J. A. Beavo, “Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells,” Journal of Immunology, vol. 171, no. 12, pp. 6421–6430, 2003. View at Google Scholar · View at Scopus
  217. D. S. Leslie, C. C. Dascher, K. Cembrola et al., “Serum lipids regulate dendritic cell CD1 expression and function,” Immunology, vol. 125, no. 3, pp. 289–301, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  218. M. A. Jakobsen, B. K. Møller, and S. T. Lillevang, “Serum concentration of the growth medium markedly affects monocyte-derived dendritic cells' phenotype, cytokine production profile and capacities to stimulate in MLR,” Scandinavian Journal of Immunology, vol. 60, no. 6, pp. 584–591, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  219. M. Loudovaris, M. Hansen, Y. Suen, S. M. Lee, P. Casing, and J. G. Bender, “Differential effects of autologous serum on CD34+ or monocyte-derived dendritic cells,” Journal of Hematotherapy and Stem Cell Research, vol. 10, no. 4, pp. 569–578, 2001. View at Google Scholar · View at Scopus
  220. A. Smed-Sörensen, M. Moll, T. Y. Cheng et al., “IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via RrγRIIa,” Blood, vol. 111, no. 10, pp. 5037–5046, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  221. K. Ohkuma, T. Sasaki, S. Kamei et al., “Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients,” Clinical and Experimental Immunology, vol. 150, no. 3, pp. 397–406, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  222. J. Xie, Y. Wang, M. E. Freeman III, B. Barlogie, and Q. Yi, “β-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells,” Blood, vol. 101, no. 10, pp. 4005–4012, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  223. O. Dumay, A. Karam, L. Vian et al., “Ultraviolet AI exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen-presenting cell function: partial protection by a broad-spectrum sunscreen,” British Journal of Dermatology, vol. 144, no. 6, pp. 1161–1168, 2001. View at Publisher · View at Google Scholar · View at Scopus
  224. M. Hochberg and C. D. Enk, “Partial protection against epidermal IL-10 transcription and langerhans cell depletion by sunscreens after exposure of human skin to UVB,” Photochemistry and Photobiology, vol. 70, no. 5, pp. 766–772, 1999. View at Google Scholar · View at Scopus
  225. K. Kang, A. C. Gilliam, G. Chen, E. Tootell, and K. D. Cooper, “In human skin, UVB initiates early induction of IL-10 over IL-12 preferentially in the expanding dermal monocytic/macrophagic population,” Journal of Investigative Dermatology, vol. 111, no. 1, pp. 31–38, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  226. V. M. Borderie, B. M. Kantelip, P. O. Genin, M. Masse, L. Laroche, and B. Y. Delbosc, “Modulation of HLA-DR and CD1a expression on human cornea with low-dose UVB irradiation,” Current Eye Research, vol. 15, no. 6, pp. 669–679, 1996. View at Google Scholar · View at Scopus
  227. P. Mitchell, C. Germain, P. L. Fiori et al., “Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development,” Infection and Immunity, vol. 75, no. 2, pp. 810–819, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  228. S. Krauss-Etschmann, R. Gruber, K. Plikat et al., “Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children,” Helicobacter, vol. 10, no. 3, pp. 214–222, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  229. A. Michalak-Stoma, J. Tabarkiewicz, A. Olender et al., “The effect of Propionibacterium acnes on maturation of dendritic cells derived from acne patients' peripherial blood mononuclear cells,” Folia Histochemica et Cytobiologica, vol. 46, no. 4, pp. 535–539, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  230. J. Correale and M. Farez, “Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection,” Journal of Neuroimmunology, vol. 190, no. 1-2, pp. 177–189, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  231. T. Agrawal, V. Vats, P. K. Wallace, S. Salhan, and A. Mittal, “Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection,” Reproductive Biology and Endocrinology, vol. 6, article no. 46, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  232. X. Chen and L. J. Chang, “Mycoplasma-mediated alterations of in vitro generation and functions of human dendritic cells,” Journal of Biomedical Science, vol. 12, no. 1, pp. 31–46, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  233. J. L. Amprey, G. F. Späth, and S. A. Porcelli, “Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani,” Infection and Immunity, vol. 72, no. 1, pp. 589–592, 2004. View at Publisher · View at Google Scholar · View at Scopus
  234. C. Favali, N. Tavares, J. Clarêncio, A. Barral, M. Barral-Netto, and C. Brodskyn, “Leishmania amazonensis infection impairs differentiation and function of human dendritic cells,” Journal of Leukocyte Biology, vol. 82, no. 6, pp. 1401–1406, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  235. M. J. Donovan, A. Jayakumar, and M. A. McDowell, “Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species,” Parasite Immunology, vol. 29, no. 10, pp. 515–524, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  236. D. Seipel, F. L. Ribeiro-Gomes, M. W. Barcelos et al., “Monocytes/macrophages infected with Toxoplasma gondii do not increase co-stimulatory molecules while maintaining their migratory ability,” APMIS, vol. 117, no. 9, pp. 672–680, 2009. View at Publisher · View at Google Scholar · View at PubMed
  237. R. T. Fujiwara, G. G. L. Cançado, P. A. Freitas et al., “Necator americanus infection: a possible cause of altered dendritic cell differentiation and eosinophil profile in chronically infected individuals,” PLoS Neglected Tropical Diseases, vol. 3, no. 3, article e399, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  238. R. Riganò, B. Buttari, E. Profumo et al., “Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response,” Infection and Immunity, vol. 75, no. 4, pp. 1667–1678, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  239. J. H. C. Kanan and B. M. Chain, “Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus,” Immunology, vol. 118, no. 2, pp. 271–278, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  240. M. Cirone, G. Lucania, P. Bergamo, P. Trivedi, L. Frati, and A. Faggioni, “Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity,” Immunology Letters, vol. 113, no. 1, pp. 40–46, 2007. View at Publisher · View at Google Scholar · View at PubMed
  241. S. Gredmark and C. Söderberg-Nauclér, “Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions,” Journal of Virology, vol. 77, no. 20, pp. 10943–10956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  242. A. Martino, E. Volpe, G. Auricchio, V. Colizzi, and P. M. Baldini, “Influence of Pertussis toxin on CD1a isoform expression in human dendritic cells,” Journal of Clinical Immunology, vol. 26, no. 2, pp. 153–159, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  243. M. Wang, P. K. Mukherjee, J. Chandra, A. A. Lattif, T. S. McCormick, and M. A. Ghannoum, “Characterization and partial purification of Candida albicans secretory IL-12 inhibitory factor,” BMC Microbiology, vol. 8, article 31, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  244. V. Sanchez, C. Hessler, A. Demonfort, J. Lang, and B. Guy, “Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain,” FEMS Immunology and Medical Microbiology, vol. 46, no. 1, pp. 113–123, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  245. O. A. Skorokhod, M. Alessio, B. Mordmüller, P. Arese, and E. Schwarzer, “Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-γ-mediated effect,” Journal of Immunology, vol. 173, no. 6, pp. 4066–4074, 2004. View at Google Scholar
  246. L. L. Bueno, C. G. Morais, I. S. Soares et al., “Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells,” Vaccine, vol. 27, no. 41, pp. 5581–5588, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  247. N. Hymery, K. Léon, F. G. Carpentier, J. L. Jung, and D. Parent-Massin, “T-2 toxin inhibits the differentiation of human monocytes into dendritic cells and macrophages,” Toxicology in Vitro, vol. 23, no. 3, pp. 509–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  248. H. K. Kyu, H. H. Ji, H. C. Jin, H. C. Kwang, and C. E. Hee, “Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes,” Journal of Korean Medical Science, vol. 21, no. 2, pp. 315–323, 2006. View at Google Scholar · View at Scopus
  249. J. Xie, J. Qian, S. Wang, M. E. Freeman, J. Epstein, and Q. Yi, “Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38,” Journal of Immunology, vol. 171, no. 9, pp. 4792–4800, 2003. View at Google Scholar · View at Scopus